CD79A and Huntington disease: On this basis, our study aimed to describe the accuracy of an immunoassay based on α-Mce1A IgA, IgM, and IgG antibodies, as well as the predictive potential of these molecules, the clinical significance of positivity and their ability to segregate HD patients, contacts, and healthy endemic controls.